Pfizer beats profit estimates on cost cuts, COVID vaccine sales
Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine. Francis Maguire reports. US says will levy tariffs on Mexico, Canada and China on Feb. 1
Pfizer gets unexpected boost from Covid vaccine and pill
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to fend off criticism from an activist investor that has argued the company squandered its pandemic gains and needs a new path forward.
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...
Other fact-checking organizations have debunked the claim; Reuters and AFP have also fact-checked similar claims that circulated in 2022 and 2023 ...
The Illinois Labor Relations Board has twice ruled that the city violated employees' collective bargaining rights by failing ...
Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.” | The company benefited from higher-than-expected sales of ...
Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.
The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback